Ex-Gilead R&D chief Bischofberger starts over as CEO of Kronos Bio; Sue Mahony steps down from Lilly Oncology
→ After spending the past 30 years before the R&D mast at Gilead, ex-research chief Norbert Bischofberger is starting over from scratch …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
